Worth reading
73In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
369
¥ million (year-on-year increase in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Financial Results PresentationFiscal year ending June 202610 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales4,166 Millions of yen+9.7%
Operating profit723 Millions of yen+9.9%
Ordinary income734 Millions of yen+16.3%
Net income518 Millions of yen+18.2%
Gross Profit Margin44.2%
Operating profit margin17.4%
Selling, general and administrative expenses1,117 Millions of yen
Results for the three months of the current quarterOverseas business revenue increased 85.7% compared with the fourth quarter. Other standalone financial figures for the three months of the quarter were not disclosed
Full-year earnings forecast
Net Sales
4,402 Millions of yen
Operating profit
790 Millions of yen
Ordinary income
798 Millions of yen
Net income for the current fiscal year
555 Millions of yen
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales103.8% of the plan for the fiscal year ending June 2026
Operating profit97.0%
Ordinary income101.3%
Net income for the current fiscal year102.9%
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Assumed Exchange Rates
Dollar¥160/USD
Euro¥182/EUR
Gross Profit MarginExpected to remain at the previous fiscal year's level
Aligner market growth rateExpected to continue growing by 10–20% annually
New initiatives
- Increase domestic and overseas orders for the new AIS lingual orthodontic appliance
- Hold AIS Certification Courses
- Sell LuxCreo 3D printers and promote the printing of soft dentures
- Strengthen marketing and sales activities in North America and the eurozone
Key KPIsA metric the company considers important as a management benchmark.
- Number of registered clinicsMore than 20,000
- Number of customer dental clinicsApproximately 7,000
- Number of dental schools in Japan29 Schools
- Overseas business revenue79% year-on-year increase
- North America revenue59% increase
Segment results
Orthodontic dental laboratory product revenue
3,392 Millions of yen+7.5%
Analog manufacturing
2,111 Millions of yen+6.9%
Digital Manufacturing
1,280 Millions of yen+8.5%
Merchandise revenue
726 Millions of yen+18.4%
Domestic revenue
3,917 Millions of yen+8.5%
Overseas revenue
248 Millions of yen+34.3%
Financial targets
Cost of shareholders’ equity9.6%
Actual ROE16.8%
DOE target5% or more
Market Size / Share
North American orthodontic market¥4.0 billion in 2024; projected to reach ¥9.2 billion in 2030
North America's global shareEstimated at approximately 45% in 2024
Number of stores and locations
The head office, branches, and the Niigata, Osaka and Nagoya offices are listed, but the number at fiscal year-end and the number of openings and closures during the period were not disclosedCapital expenditures
110 Millions of yen
Annual Dividend
Fiscal year ending June 2026¥28 (interim ¥14, year-end ¥14)
Payout ratio
TargetApproximately 50%
DOE target5% or more
| Item | Details |
|---|---|
| Document type | Financial Results Presentation |
| Fiscal Period Covered | Fiscal year ending June 2026 |
| Net Sales | 4,166 Millions of yen (YoY +9.7%) |
| Operating profit | 723 Millions of yen (YoY +9.9%) |
| Ordinary income | 734 Millions of yen (YoY +16.3%) |
| Net income | 518 Millions of yen (YoY +18.2%) |
| Gross Profit Margin | 44.2% |
| Operating profit margin | 17.4% |
| Selling, general and administrative expenses | 1,117 Millions of yen |
| Results for the three months of the current quarter | Overseas business revenue increased 85.7% compared with the fourth quarter. Other standalone financial figures for the three months of the quarter were not disclosed |
| Full-year earnings forecast | Net Sales 4,402 Millions of yen / Operating profit 790 Millions of yen / Ordinary income 798 Millions of yen / Net income for the current fiscal year 555 Millions of yen |
| Progress against full-year forecast | Net Sales 103.8% of the plan for the fiscal year ending June 2026 / Operating profit 97.0% / Ordinary income 101.3% / Net income for the current fiscal year 102.9% |
| Segment results | Orthodontic dental laboratory product revenue 3,392 Millions of yen (YoY +7.5%) / Analog manufacturing 2,111 Millions of yen (YoY +6.9%) / Digital Manufacturing 1,280 Millions of yen (YoY +8.5%) / Merchandise revenue 726 Millions of yen (YoY +18.4%) / Domestic revenue 3,917 Millions of yen (YoY +8.5%) / Overseas revenue 248 Millions of yen (YoY +34.3%) |
| Key KPIs | Number of registered clinics More than 20,000, Number of customer dental clinics Approximately 7,000, Number of dental schools in Japan 29 Schools, Overseas business revenue 79% year-on-year increase, North America revenue 59% increase |
| Number of stores and locations | The head office, branches, and the Niigata, Osaka and Nagoya offices are listed, but the number at fiscal year-end and the number of openings and closures during the period were not disclosed |
| Assumptions Underlying the Business Outlook | Assumed Exchange Rates Dollar ¥160/USD / Euro ¥182/EUR / Gross Profit Margin Expected to remain at the previous fiscal year's level / Aligner market growth rate Expected to continue growing by 10–20% annually |
| Financial targets | Cost of shareholders’ equity 9.6% / Actual ROE 16.8% / DOE target 5% or more |
| Annual Dividend | Fiscal year ending June 2026 ¥28 (interim ¥14, year-end ¥14) / Fiscal year ending June 2027 Not disclosed |
| Payout ratio | Target Approximately 50% / DOE target 5% or more |
| Capital expenditures | 110 Millions of yen |
| Market Size / Share | North American orthodontic market ¥4.0 billion in 2024; projected to reach ¥9.2 billion in 2030 / North America's global share Estimated at approximately 45% in 2024 |
| New initiatives | Increase domestic and overseas orders for the new AIS lingual orthodontic appliance, Hold AIS Certification Courses, Sell LuxCreo 3D printers and promote the printing of soft dentures, Strengthen marketing and sales activities in North America and the eurozone |
Items this document does not state (9)
Self-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsAcquisition of treasury sharesOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited increases in revenue from orthodontic dental laboratory products and merchandise, as well as growth in overseas revenue. Growth drivers for the fiscal year ending June 2027 include demand for orthodontic treatment, increased orders for the new AIS lingual orthodontic appliance, sales of LuxCreo 3D printers, and stronger sales activities in North America and Europe.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.